Trial Profile
A Double-Blind, Randomized, Placebo-Controlled Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of ABT-333 in Healthy Adults.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Oct 2010
Price :
$35
*
At a glance
- Drugs Dasabuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Abbott Laboratories
- 04 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 04 Sep 2009 Actual patient number (24) added as reported by ClinicalTrials.gov.
- 18 Aug 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.